Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Arterioscler Thromb Vasc Biol ; 34(7): 1437-45, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24855060

RESUMEN

OBJECTIVE: The site-specificity of endothelial phenotype is attributable to the local hemodynamic forces. The flow regulation of microRNAs in endothelial cells (ECs) plays a significant role in vascular homeostasis and diseases. The objective of this study was to elucidate the molecular mechanism by which the pulsatile shear flow-induced microRNA-23b (miR-23b) exerts antiproliferative effects on ECs. APPROACH AND RESULTS: We used a combination of a cell perfusion system and experimental animals to examine the flow regulation of miR-23b in modulating EC proliferation. Our results demonstrated that pulsatile shear flow induces the transcription factor Krüppel-like factor 2 to promote miR-23b biosynthesis; the increase in miR-23b then represses cyclin H to impair the activity and integrity of cyclin-dependent kinase-activating kinase (CAK) complex. The inhibitory effect of miR-23b on CAK exerts dual actions to suppress cell cycle progression, and reduce basal transcription by deactivating RNA polymerase II. Whereas pulsatile shear flow regulates the miR-23b/CAK pathway to exert antiproliferative effects on ECs, oscillatory shear flow has little effect on the miR-23b/CAK pathway and hence does not cause EC growth arrest. Such flow pattern-dependent phenomena are validated with an in vivo model on rat carotid artery: the flow disturbance induced by partial carotid ligation led to a lower expression of miR-23b and a higher EC proliferation in comparison with the pulsatile flow regions of the unligated vessels. Local delivery of miR-23b mitigated the proliferative EC phenotype in partially ligated vessels. CONCLUSIONS: Our findings unveil a novel mechanism by which hemodynamic forces modulate EC proliferative phenotype through the miR-23b/CAK pathway.


Asunto(s)
Enfermedades de las Arterias Carótidas/enzimología , Proliferación Celular , Ciclina H/metabolismo , Quinasas Ciclina-Dependientes/metabolismo , Células Endoteliales/enzimología , Células Endoteliales de la Vena Umbilical Humana/enzimología , MicroARNs/metabolismo , Transcripción Genética , Animales , Enfermedades de las Arterias Carótidas/genética , Enfermedades de las Arterias Carótidas/fisiopatología , Puntos de Control del Ciclo Celular , Células Cultivadas , Ciclina H/genética , Quinasas Ciclina-Dependientes/genética , Modelos Animales de Enfermedad , Humanos , Factores de Transcripción de Tipo Kruppel/metabolismo , Masculino , Mecanotransducción Celular , MicroARNs/genética , Perfusión , Fenotipo , Flujo Pulsátil , Interferencia de ARN , ARN Polimerasa II/metabolismo , Ratas , Ratas Sprague-Dawley , Flujo Sanguíneo Regional , Estrés Mecánico , Factores de Tiempo , Transfección , Quinasa Activadora de Quinasas Ciclina-Dependientes
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda